Methamphetamine Exposure Changed How the Brain Responds to Cannabinoids
Methamphetamine neurotoxicity increased CB1 cannabinoid receptor expression across multiple brain regions in rats, altering how they responded to cannabinoid drugs in anxiety and cognition tests.
Quick Facts
What This Study Found
Rats were exposed to a neurotoxic methamphetamine regimen (4 doses of 4 mg/kg in one day) and examined three weeks later.
Meth-exposed rats showed significantly increased CB1 receptor expression in the prefrontal cortex, caudate-putamen, basolateral amygdala, hippocampal CA1 region, and perirhinal cortex.
Behavioral responses to the cannabinoid agonist WIN 55,212-2 were altered: it produced anxiolytic (anti-anxiety) effects in meth-exposed rats but anxiogenic (anxiety-inducing) effects in controls. Meth-exposed animals also showed reduced cannabinoid effects on exploration and short-term recognition memory.
Some cannabinoid effects (locomotor reduction, acoustic startle) were not altered by meth exposure.
Key Numbers
Meth regimen: 4 mg/kg x 4 doses in one day. CB1 increased in prefrontal cortex, caudate-putamen, basolateral amygdala, CA1, and perirhinal cortex. Cannabinoid agonist produced opposite anxiety effects in meth-exposed vs control rats.
How They Did This
Rats received a neurotoxic meth regimen (4 mg/kg x 4, 2 hours apart). Three weeks later, CB1 receptor expression was measured by immunohistochemistry in multiple brain regions. A separate group was tested with the cannabinoid agonist WIN 55,212-2 in behavioral paradigms (open field, object recognition, startle reflex).
Why This Research Matters
Cannabis is the most common secondary drug among meth users. Understanding how meth neurotoxicity alters the cannabinoid system could explain different cannabis responses in meth users and has implications for dual-use populations.
The Bigger Picture
Drug interactions at the neural level can explain why people who use multiple substances may have different responses to each. Meth-induced changes in the cannabinoid system could influence vulnerability to cannabis effects and vice versa.
What This Study Doesn't Tell Us
Animal study using a specific neurotoxic meth protocol that may not reflect typical human meth use patterns. Three-week post-exposure timepoint may not reflect longer-term changes. Rats were drug-naive before the experiment.
Questions This Raises
- ?Do human meth users show similar CB1 receptor upregulation?
- ?Could cannabinoid system changes contribute to the high rate of cannabis co-use in meth users?
- ?Would CBD or THC have different effects in meth-experienced individuals?
Trust & Context
- Key Stat:
- Meth exposure increased CB1 receptors in 5 brain regions and reversed cannabinoid anxiety effects
- Evidence Grade:
- Preclinical study with a specific neurotoxic meth protocol. Well-controlled but limited to animal models with no human validation.
- Study Age:
- Published in 2010. Research on drug interactions at the receptor level has continued to develop but remains primarily preclinical.
- Original Title:
- Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
- Published In:
- Journal of psychiatric research, 44(14), 944-55 (2010)
- Authors:
- Bortolato, Marco(3), Frau, Roberto(4), Bini, Valentina, Luesu, William, Loriga, Roberta, Collu, Maria, Gessa, Gian Luigi, Ennas, M Grazia, Castelli, M Paola
- Database ID:
- RTHC-00404
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why would meth increase cannabinoid receptors?
Meth neurotoxicity damages brain cells and disrupts normal signaling. The increase in CB1 receptors may be a compensatory response, with the brain attempting to restore balance by upregulating the endocannabinoid system. This upregulation then changes how the brain responds to cannabis.
Does this explain why meth users often use cannabis?
Possibly. If meth exposure changes the cannabinoid system and makes cannabis produce different effects (like anxiety relief rather than anxiety), this could influence patterns of co-use. However, this animal study cannot directly explain human drug use decisions.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- thc-and-antibiotics-safe-cannabis-while-on
- thc-and-caffeine-most-common-drug-combo
- thc-and-diabetes-medication-blood-sugar
Cite This Study
https://rethinkthc.com/research/RTHC-00404APA
Bortolato, Marco; Frau, Roberto; Bini, Valentina; Luesu, William; Loriga, Roberta; Collu, Maria; Gessa, Gian Luigi; Ennas, M Grazia; Castelli, M Paola. (2010). Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.. Journal of psychiatric research, 44(14), 944-55. https://doi.org/10.1016/j.jpsychires.2010.03.002
MLA
Bortolato, Marco, et al. "Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.." Journal of psychiatric research, 2010. https://doi.org/10.1016/j.jpsychires.2010.03.002
RethinkTHC
RethinkTHC Research Database. "Methamphetamine neurotoxicity increases brain expression and..." RTHC-00404. Retrieved from https://rethinkthc.com/research/bortolato-2010-methamphetamine-neurotoxicity-increases-brain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.